At the European Association of Urology Congress 2026 (EAU26), the session “Living with urinary incontinence as a comorbidity: patient perspectives” explored an important but often overlooked issue for people affected by bladder cancer: urinary continence and its impact on everyday life.
Urinary incontinence can occur as a result of the disease itself or as a consequence of treatments such as surgery or urinary reconstruction. While the focus of care is often on treating the cancer,
At the European Association of Urology Congress 2026 (EAU26), we participated in the session “BCLEAR: Shared Decisions, Stronger Care in Bladder Cancer – Addressing Clinician Needs Across Europe”. The session brought together clinicians, primary care representatives and patient advocates to discuss how shared decision-making can be strengthened across the bladder cancer care pathway.
During the session, WBCPC Executive Director Alex Filicevas, presented insights from the Global Bladder Cancer Patient and Carer Survey,
The World Bladder Cancer Patient Coalition (WBCPC) is attending the European Association of Urology Congress 2026, one of the world’s leading events in urology, where patient advocacy and patient perspectives are increasingly recognised as an essential part of improving cancer care.
Today, during EAU Patient Day, WBCPC contributed to the Patient Advocacy Poster Session, which showcases initiatives from patient organisations working to strengthen awareness, diagnosis and patient support.
From 13–16 March 2026, the World Bladder Cancer Patient Coalition (WBCPC) will be attending the European Association of Urology (EAU) Congress in London, one of the largest international meetings dedicated to urology research, clinical practice and patient care.
For the bladder cancer community, the presence of WBCPC at EAU is important. It ensures that the patient perspective is represented in conversations where new research is presented and where clinical pathways and care approaches are discussed.
The World Bladder Cancer Patient Coalition (WBCPC) took part in the 2026 edition of the ASCO Genitourinary Cancers Symposium, held in San Francisco from February 27–29, 2026. This international meeting brings together clinicians, researchers and organisations working in genitourinary (GU) cancers, including bladder cancer, to share the latest scientific developments and clinical updates.
This year, our Executive Director, Alex Filicevas, presented a poster titled: “Fostering Inclusive Language in Genitourinary Cancer Research” during the Prostate Cancer and Urothelial Carcinoma session.
WBCPC took part in a special meeting of the European Parliament Intergroup on Cancer and Rare Diseases on the eve of World Cancer Day. Members of the European Parliament, patient organisations, healthcare professionals, and civil society representatives joined the discussion as negotiations begin on the next Multiannual Financial Framework for 2028 to 2034.
Participants discussed how the EU can sustain the momentum created by Europe’s Beating Cancer Plan and the EU Mission on Cancer.
The World Bladder Cancer Patient Coalition attended the European Patients’ Forum (EPF) Congress 2025, held on November 26-27, in Brussels. The congress brought together patient organisations, health experts, policymakers, and industry representatives to explore how healthcare systems can become more resilient, inclusive, and patient-centred.
Under the theme Shaping the Future of Healthcare, the congress hosted a range of workshops examining how European health systems can become more prepared,
WBCPC participated for the first time in the World Cancer Leaders’ Summit, held on November 18–20, 2025 in Melbourne, Australia. The invitation-only event, hosted by the Union for International Cancer Control (UICC) , brings together leaders in cancer control from across the world to exchange ideas, shape future policy priorities and explore new opportunities for collaboration. This year’s Summit themed Bridging Divides, Building Futures, welcomed more than 400 participants,
The World Bladder Cancer Patient Coalition took part in the European Cancer Summit 2025 organised by European Cancer Organisation, held on November 19-20 in Brussels. Bringing together policymakers, clinicians, researchers, industry representatives, and patient advocates, the summit focused on how cancer care must adapt in an uncertain political and economic environment.
This year’s theme, “Cancer in a Changing Global Landscape: Challenges and Commitments”, highlighted the importance of unity, innovation, and wise investment to protect progress in cancer care.
The Associazione PaLiNUro held its Annual Congress on November 15, 2025 in Milan, Italy, which the World Bladder Cancer Patient Coalition (WBCPC) had the opportunity to attend in person.
The programme brought together patients, patient advocates, healthcare professionals and experts to exchange the latest knowledge in bladder cancer care. Edoardo Fiorini, President of Associazione PaLiNUro, opened the Congress with an insightful overview of the future direction of the organisation.
For general information, information about membership or policy information, please contact the WBCPC Secretariat at info@worldbladdercancer.org
For general information, information about membership or policy information, please contact the WBCPC Secretariat at info@worldbladdercancer.org
